This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investors

Investor Information

ICON is a Global Contract Research Organisation (CRO). We specialise in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies.

Our services can be implemented separately or as part of a comprehensive full service clinical programme that can help expedite the time it takes to bring a drug to market and monitor its performance and safety post approval.

Share Price NASDAQ

Price

Change

High

Copyright West LLC. Minimum 15 minutes delayed.


Recent News

Apr 03, 2020 ICON Signs New Service Agreement With Pfizer

Recent News

Apr 03, 2020

ICON Signs New Service Agreement With Pfizer


Upcoming Events

April 23, 2020 at 9:00 AM EDT Q1 2020 Conference Call & Webcast

Upcoming Events

April 23, 2020 at 9:00 AM EDT

Q1 2020 Conference Call & Webcast


Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.

Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.



Search Investor